Quarterly report pursuant to Section 13 or 15(d)

Condensed Interim Statement of Stockholder's Equity

v2.3.0.15
Condensed Interim Statement of Stockholder's Equity (USD $)
3 Months Ended 8 Months Ended
Sep. 30, 2011
Sep. 30, 2011
Underwriters' discount and offering expenses   $ (11,140,311)
Proceeds from private placement of 7,000,000 warrants on May 18, 2011   5,250,000
Proceeds subject to possible redemption of 17,885,552 shares   (178,574,414)
Net loss (312,761) (485,274)
Ending Balances 5,000,001 5,000,001
Common Stock
   
Forfeiture of common stock issued to Sponsor(in shares)   (248,598)
Forfeiture of common stock issued to Sponsor   (25)
Ending Balances (in shares) 23,161,585 23,161,585
Ending Balances 2,316 2,316
Common Stock | Issuance During Period 1st | Sponsor
   
Sale of common stock (in shares)   4,417,683
Sale of common stock   442
Common Stock | Issuance During Period 2nd | IPO
   
Sale of common stock (in shares)   18,992,500
Sale of common stock   1,899
Additional Paid-in Capital
   
Underwriters' discount and offering expenses   (11,140,311)
Proceeds from private placement of 7,000,000 warrants on May 18, 2011   5,250,000
Proceeds subject to possible redemption of 17,885,552 shares   (178,574,414)
Forfeiture of common stock issued to Sponsor   25
Ending Balances 5,482,959 5,482,959
Additional Paid-in Capital | Issuance During Period 1st | Sponsor
   
Sale of common stock   24,558
Additional Paid-in Capital | Issuance During Period 2nd | IPO
   
Sale of common stock   189,923,101
Deficit Accumulated During the Development Stage
   
Net loss   (485,274)
Ending Balances (485,274) (485,274)
Issuance During Period 1st | Sponsor
   
Sale of common stock   25,000
Issuance During Period 2nd | IPO
   
Sale of common stock   $ 189,925,000